Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
- 1 November 1996
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 348 (9036), 1212-1215
- https://doi.org/10.1016/s0140-6736(96)04444-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Famciclovir treatment of hepatitis B virus recurrence after orthotopic liver tnrasplantation ? A pilot studyHepatology, 1995
- Efficacy of vaccination against hepatitis B virus in liver transplant recipients (1) Liver Transplant Unit (2) Department of Virology, H pital Henri Mondor, 94010 Cr teil, FranceHepatology, 1995
- PROSTAGLANDIN E IN THE TREATMENT OF RECURRENT HEPATITIS B INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATIONTransplantation, 1994
- ‘EUROHEP’ consensus report on the management of liver transplantation for hepatitis B virus infectionJournal of Hepatology, 1994
- Response to hepatitis B vaccination by liver transplant candidatesDigestive Diseases and Sciences, 1992
- Hepatitis B virus and apparent fulminant non-A, non-B hepatitisThe Lancet, 1992
- Hepatitis B virus reinfection after orthotopic liver transplantation: Serological and clinical implicationsJournal of Hepatology, 1992
- PERSISTENT HEPATITIS B VIRUS INFECTION OF MONONUCLEAR BLOOD CELLS WITHOUT CONCOMITANT LIVER INFECTIONTransplantation, 1990
- MYOPATHY AS POSSIBLE SIDE-EFFECT OF CYCLOSPORINThe Lancet, 1989